W. W. Shen, A history of antipsychotic drug development, Comprehensive Psychiatry, vol.40, issue.6, pp.407-421, 1999.
DOI : 10.1016/S0010-440X(99)90082-2

J. Delay and P. Deniker, Méthodes chimiothérapiques en psychiatrie. Les nouveaux médicaments psychotropes

A. R. Maher, Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults, JAMA, vol.306, issue.12, pp.306-1359, 2011.
DOI : 10.1001/jama.2011.1360

L. Caihol, Borderline personality disorder and mental healthcare service use among adolescents

P. K. Fazeli, Psychotropic medication use in anorexia nervosa between, 1997.

J. Alonso, Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project, Acta Psychiatr Scand, issue.420, pp.55-64, 2004.

I. Gasquet, [Psychotropic drug use and mental psychiatric disorders in France; results of the general population ESEMeD/MHEDEA 2000 epidemiological study], Encephale, issue.2, pp.31-195, 2005.

I. C. Chien, Trends in the Use of Psychotropic Drugs in Taiwan: A Population-Based National Health Insurance Study, 1997???2004, Psychiatric Services, vol.58, issue.4, pp.554-561, 1997.
DOI : 10.1176/ps.2007.58.4.554

M. Mirandola, Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999.

A. Grolleau, Usage et congruence diagnostique des traitements ?? vis??e psychotrope??: r??sultats de l???enqu??te sant?? mentale en population g??n??rale en France m??tropolitaine, L'Enc??phale, vol.34, issue.4, pp.352-361, 2008.
DOI : 10.1016/j.encep.2007.07.011

M. Olfson, National Trends in the Office-Based Treatment of Children, Adolescents, and Adults With Antipsychotics, Archives of General Psychiatry, vol.69, issue.12, pp.1-10, 2012.
DOI : 10.1001/archgenpsychiatry.2012.647

P. Prah, National changes in oral antipsychotic treatment for people with schizophrenia in primary care between 1998 and 2007 in the United Kingdom, Pharmacoepidemiology and Drug Safety, vol.192, issue.6, pp.161-170, 2012.
DOI : 10.1002/pds.2213

P. Blin, [Neuroleptic drug utilization among schizophrenic outpatients]. Rev Epidemiol Sante Publique, pp.601-614, 2005.

H. Verdoux and B. Begaud, Pharmaco-epidemiology: what do (and don't) we know about utilisation and impact of psychotropic medications in real-life conditions?, The British Journal of Psychiatry, vol.185, issue.2, pp.93-97, 2004.
DOI : 10.1192/bjp.185.2.93

B. L. Strom and S. E. Kimmel, Textbook of pharmacoepidemiology, 2006.

H. G. Eichler, Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers, Nature Reviews Drug Discovery, vol.28, issue.4, pp.277-91, 2010.
DOI : 10.1038/nrd3079

D. Institutdeveillesanitaire and E. Jougla, Impact sanitaire de la vague de chaleur d'août 2003 en France - Bilan et perspectives, 2003.

T. S. Jones, Morbidity and Mortality Associated With the July 1980 Heat Wave in St Louis and Kansas City, Mo, JAMA: The Journal of the American Medical Association, vol.247, issue.24, pp.247-3327, 1982.
DOI : 10.1001/jama.1982.03320490025030

E. M. Kilbourne, Risk factors for heatstroke. A case-control study, JAMA: The Journal of the American Medical Association, vol.247, issue.24, pp.3332-3338, 1982.
DOI : 10.1001/jama.247.24.3332

J. Belmin, Level of dependency: a simple marker associated with mortality during the 2003 heatwave among French dependent elderly people living in the community or in institutions, Age and Ageing, vol.36, issue.3, pp.298-303, 2007.
DOI : 10.1093/ageing/afm026

M. P. Naughton, Heat-related mortality during a 1999 heat wave in Chicago, American Journal of Preventive Medicine, vol.22, issue.4, pp.221-228, 2002.
DOI : 10.1016/S0749-3797(02)00421-X

S. Vandentorren, heat wave in France: risk factors for death of elderly people living at home, Eur J Public Health, issue.6, pp.16-583, 2003.

R. Kaiser, Heat-Related Death and Mental Illness During the 1999 Cincinnati Heat Wave, The American Journal of Forensic Medicine and Pathology, vol.22, issue.3
DOI : 10.1097/00000433-200109000-00022

A. Fourrier, Benzodiazepine use in an elderly community-dwelling population, European Journal of Clinical Pharmacology, vol.57, issue.5, pp.419-444, 2001.
DOI : 10.1007/s002280100326

V. Institut-de and . Sanitaire, Etude des facteurs de risque de décès des personnes âgées résidant à domicile, durant la vague de chaleur d'août 2003, 2004.

N. Salles-montaudon, ??volution des traitements m??dicamenteux des personnes ??g??es vivant ?? domicile, La Revue de M??decine Interne, vol.21, issue.8, pp.664-71, 2000.
DOI : 10.1016/S0248-8663(00)80021-1

C. B. Taylor, Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction, Arch Gen Psychiatry, issue.7, pp.62-792, 2005.

W. V. Vieweg, Treatment of Depression in Patients with Coronary Heart Disease, The American Journal of Medicine, vol.119, issue.7, pp.567-73, 2006.
DOI : 10.1016/j.amjmed.2006.02.037

. Statacorp, Stata Statistical Software: Release 9.0, 2005.

D. W. Hosmer, A comparison of goodness-of-fit tests for the logistic regression model

A. Pariente, Prevalence of cholinesterase inhibitors in subjects with dementia in Europe, Pharmacoepidemiology and Drug Safety, vol.2005, issue.146, pp.655-60, 2008.
DOI : 10.1002/pds.1613

F. Empereur, Factors associated with the consumption of psychotropic drugs in a cohort of men and women aged 50 and over, Journal of Clinical Pharmacy and Therapeutics, vol.39, issue.1, pp.61-69, 2003.
DOI : 10.1016/0037-7856(75)90103-1

V. Institut-de and . Sanitaire, Etude des facteurs de risque de décès des personnes âgées résidant en établissement durant la vague de chaleur d'août, 2003.

A. Davido, Risk factors for heat related death during the August 2003 heat wave in Paris, France, in patients evaluated at the emergency department of the Hopital Europeen Georges Pompidou, Emergency Medicine Journal, vol.23, issue.7, pp.515-523, 2006.
DOI : 10.1136/emj.2005.028290

G. Galula, Consommation de psychotropes chez les personnes âgées décédées lors de la canicule d'août 2003, Rev Prat Med Gen, vol.20737, issue.736, pp.729-733, 2006.

L. S. Schneider, K. S. Dagerman, and P. Insel, Risk of Death With Atypical Antipsychotic Drug Treatment for Dementia, JAMA, vol.294, issue.15, pp.294-1934, 2005.
DOI : 10.1001/jama.294.15.1934

S. S. Gill, Antipsychotic Drug Use and Mortality in Older Adults with Dementia, Annals of Internal Medicine, vol.146, issue.11, pp.775-86, 2007.
DOI : 10.7326/0003-4819-146-11-200706050-00006

C. Montout, Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patients, Schizophrenia Research, vol.57, issue.2-3, pp.147-56, 2002.
DOI : 10.1016/S0920-9964(01)00325-5

A. B. Hill, The environment and disease: association or causation?, Journal of the Royal Society of Medicine, vol.88, issue.1, pp.295-300, 1965.
DOI : 10.1177/0141076814562718

U. Tacke and E. Venalainen, Heat stress and neuroleptic drugs., Journal of Neurology, Neurosurgery & Psychiatry, vol.50, issue.7
DOI : 10.1136/jnnp.50.7.937-a

L. Lissner, Measuring food intake in studies of obesity, Public Health Nutrition, vol.43, issue.6a, pp.889-92, 2002.
DOI : 10.1038/sj.ejcn.1600620

D. G. Robinson, Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder, American Journal of Psychiatry, vol.156, issue.4, pp.544-549, 1999.

I. Gasquet, Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study, International Clinical Psychopharmacology, vol.20, issue.4, pp.199-205, 2005.
DOI : 10.1097/00004850-200507000-00002

A. Ucok, One year outcome in first episode schizophrenia. Predictors of relapse. European Archives of Psychiatry and Clinical Neuroscience, pp.37-43, 2006.

C. G. Huber, D. Naber, and M. Lambert, Incomplete remission and treatment resistance in first-episode psychosis: definition, prevalence and predictors, Expert Opinion on Pharmacotherapy, vol.2, issue.12, pp.2027-2038, 2008.
DOI : 10.1080/j.1440-1614.2005.01516.x

P. Whitty, Predictors of outcome in first-episode schizophrenia over the first 4 years of illness, Psychological Medicine, vol.28, issue.08, pp.38-1141, 2008.
DOI : 10.1111/j.1600-0447.1984.tb02497.x

C. White, Predictors of 10-year outcome of first-episode psychosis, Psychological Medicine, vol.8, issue.09, pp.1447-1456, 2009.
DOI : 10.1016/S0920-9964(02)00348-1

E. Simonsen, Early identification of non-remission in first-episode psychosis in a two-year outcome study, Acta Psychiatrica Scandinavica, vol.9, issue.Suppl 438, pp.375-383, 2010.
DOI : 10.1111/j.1600-0447.2010.01598.x

R. Schennach-wolff, An early improvement threshold to predict response and remission in first-episode schizophrenia, The British Journal of Psychiatry, vol.196, issue.6, pp.460-466, 2010.
DOI : 10.1192/bjp.bp.109.069328

D. S. Nagin, Group-Based Modeling of Development, 2005.
DOI : 10.4159/9780674041318

V. T. Cole, Using latent class growth analysis to form trajectories of premorbid adjustment in schizophrenia., Journal of Abnormal Psychology, vol.121, issue.2, pp.388-395, 2012.
DOI : 10.1037/a0026922

J. B. Pingault, Childhood Trajectories of Inattention and Hyperactivity and Prediction of Educational Attainment in Early Adulthood: A 16-Year Longitudinal Population-Based Study, American Journal of Psychiatry, vol.168, issue.11
DOI : 10.1176/appi.ajp.2011.10121732

J. B. Pingault, Childhood trajectories of inattention, hyperactivity and oppositional behaviors and prediction of substance abuse/dependence: a 15-year longitudinal population-based study, Molecular Psychiatry, vol.27, issue.7
DOI : 10.1001/archgenpsychiatry.2007.41

S. Z. Levine and J. Rabinowitz, Trajectories and Antecedents of Treatment Response Over Time in Early-Episode Psychosis, Schizophrenia Bulletin, vol.36, issue.3, pp.624-632, 2010.
DOI : 10.1093/schbul/sbn120

M. Case, The heterogeneity of antipsychotic response in the treatment of schizophrenia, Psychological Medicine, vol.41, issue.06, pp.1291-1300, 2011.
DOI : 10.1017/S0033291710001893

Y. Barak, H. Szor, R. Kimhi, E. Kam, R. Mester et al., Survey of patient satisfaction in adult psychiatric outpatient clinics, European Psychiatry, vol.16, issue.2, pp.131-133, 2001.
DOI : 10.1016/S0924-9338(01)00551-X

C. Barbui, M. Nose, M. A. Mazzi, J. Bindman, M. Leese et al., Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries, International Clinical Psychopharmacology, vol.21, issue.2, pp.73-79, 2006.
DOI : 10.1097/01.yic.0000185022.48279.db

P. Chue, The relationship between patient satisfaction and treatment outcomes in schizophrenia, Journal of Psychopharmacology, vol.20, issue.6 suppl, pp.38-56, 2006.
DOI : 10.1177/1359786806071246

A. V. Diez-roux, Multilevel Analysis in Public Health Research, Annual Review of Public Health, vol.21, issue.1, pp.171-192, 2000.
DOI : 10.1146/annurev.publhealth.21.1.171

R. Duggins and I. Shaw, Examining the concept of patient satisfaction in patients with a diagnosis of schizophrenia: a qualitative study, Psychiatric Bulletin, vol.30, issue.4, pp.142-145, 2006.
DOI : 10.1192/pb.30.4.142

M. Edlinger, A. Hofer, M. A. Rettenbacher, S. Baumgartner, C. G. Widschwendter et al., Factors influencing the choice of new generation antipsychotic medication in the treatment of patients with schizophrenia, Schizophrenia Research, vol.113, issue.2-3, pp.2-3, 2009.
DOI : 10.1016/j.schres.2009.06.008

R. L. Fong, K. D. Bertakis, and P. Franks, Association between Obesity and Patient Satisfaction*, Obesity, vol.282, issue.8, pp.1402-1411, 2006.
DOI : 10.1038/oby.2006.159

D. Food and . Administration, Guidance for Industry Patient-Reported Outcome Measures: use in medical product development to support labeling claims, 2009.

M. Fujikawa, T. Togo, A. Yoshimi, J. Fujita, M. Nomoto et al., Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.32, issue.3, pp.755-760, 2008.
DOI : 10.1016/j.pnpbp.2007.12.002

I. Gasquet, S. Tcherny-lessenot, J. P. Lepine, and B. Falissard, Patient satisfaction with psychotropic drugs: sensitivity to??change and??relationship to??clinical status, quality-of-life, compliance and??effectiveness of??treatment. Results from a??nation-wide 6-month prospective study, European Psychiatry, vol.21, issue.8, pp.531-538, 2006.
DOI : 10.1016/j.eurpsy.2005.09.014

G. J. Gerber and P. N. Prince, Measuring Client Satisfaction With Assertive Community Treatment, Psychiatric Services, vol.50, issue.4, pp.546-550, 1999.
DOI : 10.1176/ps.50.4.546

G. M. Gharabawi, A. Greenspan, M. F. Rupnow, C. Kosik-gonzalez, C. A. Bossie et al., Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: Data from a randomized double-blind trial, BMC Psychiatry, vol.8, issue.1, p.45, 2006.
DOI : 10.2307/1390833

I. Goetz, M. Tohen, C. Reed, M. Lorenzo, and E. Vieta, Functional impairment in patients with mania: baseline results of the EMBLEM study, Bipolar Disorders, vol.30, issue.1-2, pp.1-2, 2007.
DOI : 10.1111/j.1399-5618.2004.00111.x

R. Gray, D. Rofail, J. Allen, and T. Newey, A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication, Journal of Advanced Nursing, vol.93, issue.1, pp.31-37, 2005.
DOI : 10.1016/0277-9536(91)90025-8

W. Guy, CGI: Clinical Global Impressions, ECDEU Assessment Manual for Psychopharmacology . U.S. Department of Health, Education, and Welfare, 1976.

B. M. Kuehn, Cognitive Therapy May Aid Patients With Schizophrenia, JAMA, vol.306, issue.16, p.1749, 2011.
DOI : 10.1001/jama.2011.1553

J. Lebow, Pragmatic decisions in the evaluation of consumer satisfaction with mental health treatment, Evaluation and Program Planning, vol.5, issue.4, pp.349-356, 1982.
DOI : 10.1016/0149-7189(82)90007-6

D. Leguay, A. Cochet, G. Matignon, A. Hairy, O. Fortassin et al., Social Autonomy Scale. First validation data, Encéphale, vol.24, issue.2, pp.108-119, 1998.

D. Leguay, F. Rouillon, J. M. Azorin, I. Gasquet, J. Y. Loze et al., ??volution de l???autonomie sociale chez des patients schizophr??nes selon les prises en charge. L?????tude ESPASS, L'Enc??phale, vol.36, issue.5, pp.397-407, 2010.
DOI : 10.1016/j.encep.2010.01.004

H. Lester, J. Q. Tritter, and E. England, Satisfaction with primary care: the perspectives of people with schizophrenia, Family Practice, vol.20, issue.5, pp.508-513, 2003.
DOI : 10.1093/fampra/cmg502

S. Leucht, C. Corves, D. Arbter, R. R. Engel, C. Li et al., Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis, The Lancet, vol.373, issue.9657, pp.31-41, 2009.
DOI : 10.1016/S0140-6736(08)61764-X

F. Limosin, I. Gasquet, D. Leguay, J. M. Azorin, and F. Rouillon, Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia, Acta Psychiatrica Scandinavica, vol.171, issue.1, pp.19-25, 2008.
DOI : 10.1056/NEJM199910073411501

T. M. Lincoln, E. Lullmann, and W. Rief, Correlates and Long-Term Consequences of Poor Insight in Patients With Schizophrenia. A Systematic Review, Schizophrenia Bulletin, vol.33, issue.6, pp.1324-1342, 2007.
DOI : 10.1093/schbul/sbm002

L. Lissner, Measuring food intake in studies of obesity, Public Health Nutrition, vol.43, issue.6a, pp.889-892, 2002.
DOI : 10.1038/sj.ejcn.1600620

K. M. Mazor, B. E. Clauser, T. Field, R. A. Yood, and J. H. Gurwitz, A Demonstration of the Impact of Response Bias on the Results of Patient Satisfaction Surveys, Health Services Research, vol.38, issue.(3), pp.1403-1417, 2002.
DOI : 10.1111/1475-6773.11194

D. J. Miklowitz, M. W. Otto, E. Frank, N. A. Reilly-harrington, J. N. Kogan et al., Intensive Psychosocial Intervention Enhances Functioning in Patients With Bipolar Depression: Results From a 9-Month Randomized Controlled Trial, American Journal of Psychiatry, vol.164, issue.9, pp.1340-1347, 2007.
DOI : 10.1176/appi.ajp.2007.07020311

H. J. Moller, Antipsychotic and antidepressive effects of second generation antipsychotics, European Archives of Psychiatry and Clinical Neuroscience, vol.23, issue.3, pp.190-201, 2005.
DOI : 10.1007/s00406-005-0587-5

L. Moret, J. M. Nguyen, C. Volteau, B. Falissard, P. Lombrail et al., Evidence of a non-linear influence of patient age on satisfaction with hospital care, International Journal for Quality in Health Care, vol.19, issue.6, pp.382-389, 2007.
DOI : 10.1093/intqhc/mzm041

H. Peyre, J. Coste, and A. Leplege, Identifying type and determinants of missing items in quality of life questionnaires: Application to the SF-36 French version of the 2003 Decennial Health Survey, Health and Quality of Life Outcomes, vol.8, issue.1, pp.1-6, 2010.
DOI : 10.1186/1477-7525-8-16

H. Peyre, A. Leplege, and J. Coste, Missing data methods for dealing with missing items in quality of life questionnaires. A comparison by simulation of personal mean score, full information maximum likelihood, multiple imputation, and hot deck techniques applied to the SF-36 in the French 2003 decennial health survey, Quality of Life Research, vol.338, issue.2, pp.287-300, 2003.
DOI : 10.1007/s11136-010-9740-3

J. Rabinowitz, E. J. Bromet, and M. Davidson, Short Report: Comparison of Patient Satisfaction and Burden of Adverse Effects With Novel and Conventional Neuroleptics: A Naturalistic Study, Schizophrenia Bulletin, vol.27, issue.4, pp.597-600, 2001.
DOI : 10.1093/oxfordjournals.schbul.a006899

M. Ruggeri, A. Lasalvia, G. Bisoffi, G. Thornicroft, J. L. Vazquez-barquero et al., Satisfaction With Mental Health Services Among People With Schizophrenia in Five European Sites: Results From the EPSILON Study, Schizophrenia Bulletin, vol.29, issue.2, pp.229-245, 2003.
DOI : 10.1093/oxfordjournals.schbul.a007000

R. K. Salokangas, T. Honkonen, E. Stengard, and A. M. Koivisto, Subjective Life Satisfaction and Living Situations of Persons in Finland With Long-Term Schizophrenia, Psychiatric Services, vol.57, issue.3, pp.373-381, 2006.
DOI : 10.1176/appi.ps.57.3.373

J. Scheffer, Dealing with missing data, Res. Lett. Inf. Math. Sci, vol.3, pp.153-160, 2002.

R. Tandon, R. F. Devellis, J. Han, H. Li, S. Frangou et al., Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder, Psychiatry Research, vol.136, issue.2-3, pp.2-3, 2005.
DOI : 10.1016/j.psychres.2005.05.006

G. Thornicroft, M. Tansella, T. Becker, M. Knapp, M. Leese et al., The personal impact of schizophrenia in Europe, Schizophrenia Research, vol.69, issue.2-3, pp.2-3, 2004.
DOI : 10.1016/S0920-9964(03)00191-9

A. Watanabe, I. Shibata, and T. Kato, Differences of satisfaction with medication between patients with schizophrenia treated with typical antipsychotics and atypical antipsychotics, Psychiatry and Clinical Neurosciences, vol.58, issue.3, pp.268-273, 2004.
DOI : 10.1016/S0006-3223(02)01370-7

K. Wilson-d-'almeida, A. Karrow, M. C. Bralet, N. Bazin, M. C. Hardy-bayle et al., In patients with schizophrenia, symptoms improvement can be uncorrelated with quality of life improvement, Eur, 2011.

T. Wykes, V. Huddy, C. Cellard, S. R. Mcgurk, and P. Czobor, A Meta-Analysis of Cognitive Remediation for Schizophrenia: Methodology and Effect Sizes, American Journal of Psychiatry, vol.168, issue.5, pp.472-485, 2011.
DOI : 10.1176/appi.ajp.2010.10060855

. Direction-de-la-politique-médicale, Assistance Publique-Hôpitaux de Paris 3, avenue Victoria 75004 Paris, France References [1] American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders -fourth edition, 1994.

M. Asadi-lari, C. Packham, and D. Gray, Patients' satisfaction and quality of life in coronary artery disease, Health Qual Life Outcomes, vol.13, pp.57-63, 2003.

M. Atkinson, A. Sinha, S. Hass, S. Colman, R. Kumar et al., Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease, Health and Quality of Life Outcomes, vol.2, issue.1, pp.12-24, 2004.
DOI : 10.1186/1477-7525-2-12

A. Awad and L. Voruganti, New Antipsychotics, Compliance, Quality of Life, and Subjective Tolerability???Are Patients Better Off?, The Canadian Journal of Psychiatry, vol.157, issue.5, pp.297-302, 2004.
DOI : 10.1177/070674370404900504

A. Awad, L. Voruganti, R. Heslegrave, and T. Hogan, Assessment of the patient's subjective experience in acute neuroleptic treatment: implications for compliance and outcome, Int Clin Psychopharmacol, vol.116, issue.2, pp.55-64, 1996.

J. Azorin, A. Luquiens, E. Aubrun, C. Reed, I. Gasquet et al., [Management of patients with acute manic or mixed episodes and outcome at three months] Affective and instrumental components in the physician-patient relationship: an additional dimension of interaction theory compliance: a determinant of patient satisfaction?, Encephale J Health Soc Behav Angle Orthod, vol.367218759, pp.226-35170, 1980.

C. Bradley, Diabetes treatment satisfaction questionnaire. Change version for use alongside status version provides appropriate solution where ceiling effects occur, Diabetes Care, vol.22, issue.3, pp.530-532, 1999.
DOI : 10.2337/diacare.22.3.530

J. Cappelleri, W. Cefalu, J. Rosenstock, I. Kourides, and R. Gerber, Treatment satisfaction in type 2 diabetes: A comparison between an inhaled insulin regimen and a subcutaneous insulin regimen, Clinical Therapeutics, vol.24, issue.4, pp.552-64, 2002.
DOI : 10.1016/S0149-2918(02)85131-1

R. Cattell, The Scree Test For The Number Of Factors, Multivariate Behavioral Research, vol.1, issue.2, pp.245-76, 1966.
DOI : 10.1207/s15327906mbr0102_10

D. Cherkin, R. Deyo, and A. Berg, Evaluation of a Physician Education Intervention to Improve Primary Care for Low-Back Pain II, Spine, vol.16, issue.10, pp.1173-1181, 1976.
DOI : 10.1097/00007632-199110000-00008

B. Clotet, J. Carmena, F. Pulido, I. Luque, and F. Rodriguez-alcantara, Adherence, quality of life, and general satisfaction with co-formulated zidovudine, lamivudine, and abacavir on antiretroviral-experienced patients, HIV Clin Trials, vol.5, pp.33-42, 2004.

L. Cronbach, Coefficient alpha and the internal structure of tests, Psychometrika, vol.8, issue.3, pp.297-334, 1951.
DOI : 10.1007/BF02310555

J. Day, R. Bentall, C. Roberts, F. Randall, A. Rogers et al., Attitudes Toward Antipsychotic Medication, Archives of General Psychiatry, vol.62, issue.7, pp.717-741, 2005.
DOI : 10.1001/archpsyc.62.7.717

J. Day, R. Bentall, and S. Warner, Schizophrenic patients' experiences of neuroleptic medication: a Q-methodological investigation, Acta Psychiatrica Scandinavica, vol.301, issue.380, pp.397-402, 1996.
DOI : 10.1037//0022-006X.61.3.455

L. De-haan, M. Weisfelt, P. Dingemans, D. Linszen, and L. Wouters, Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale, Psychopharmacology, vol.162, issue.1, pp.24-32, 2002.
DOI : 10.1007/s00213-002-1054-x

B. Falissard, Mesurer la subjectivité en santé : perspective méthodologique et statistique], 2001.

R. Fitzpatrick, Surveys of patients satisfaction: I--Important general considerations., BMJ, vol.302, issue.6781, pp.887-896, 1991.
DOI : 10.1136/bmj.302.6781.887

I. Gasquet, S. Tcherny-lessenot, J. Lepine, and B. Falissard, Patient satisfaction with psychotropic drugs: sensitivity to??change and??relationship to??clinical status, quality-of-life, compliance and??effectiveness of??treatment. Results from a??nation-wide 6-month prospective study, European Psychiatry, vol.21, issue.8, pp.531-539, 2006.
DOI : 10.1016/j.eurpsy.2005.09.014

I. Gasquet, S. Villeminot, D. Santos, C. Vallet, O. Verdier et al., Adaptation culturelle et validation de questionnaires de satisfaction ?? l'??gard du syst??me de sant?? fran??ais, Sant?? Publique, vol.15, issue.4, pp.383-402, 2003.
DOI : 10.3917/spub.034.0383

I. Gasquet, S. Villeminot, C. Estaquio, P. Durieux, P. Ravaud et al., Construction of a questionnaire measuring outpatients' opinion of quality of hospital consultation departments, Health and Quality of Life Outcomes, vol.2, issue.1, p.43, 2004.
DOI : 10.1186/1477-7525-2-43

G. Gharabawi, A. Greenspan, M. Rupnow, C. Kosik-gonzalez, C. Bossie et al., Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: Data from a randomized double-blind trial, BMC Psychiatry, vol.8, issue.1, p.45, 2006.
DOI : 10.2307/1390833

A. Gigantesco, R. Morosini, and A. Bazzoni, Quality of psychiatric care: validation of an instrument for measuring inpatient opinion, International Journal for Quality in Health Care, vol.15, issue.1, pp.73-81, 2003.
DOI : 10.1093/intqhc/15.1.73

T. Hogan, A. Awad, and R. Eastwood, A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity, Psychological Medicine, vol.34, issue.01, pp.177-83, 1983.
DOI : 10.1111/j.1600-0447.1963.tb07482.x

R. Kalda, K. Polluste, and M. Lember, Patient satisfaction with care is associated with personal choice of physician, Health Policy, vol.64, issue.1, pp.55-62, 2003.
DOI : 10.1016/S0168-8510(02)00160-4

O. Kampman, K. Lehtinen, V. Lassila, E. Leinonen, O. Poutanen et al., Attitudes towards neuroleptic treatment: Reliability and validity of the Attitudes towards Neuroleptic Treatment (ANT) questionnaire, Schizophrenia Research, vol.45, issue.3, pp.223-257, 2000.
DOI : 10.1016/S0920-9964(99)00204-2

N. Kerse, S. Buetow, A. Mainous, G. Young, G. Coster et al., Physician-Patient Relationship and Medication Compliance: A Primary Care Investigation, The Annals of Family Medicine, vol.2, issue.5, pp.455-61, 2004.
DOI : 10.1370/afm.139
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1466710

H. Koivumaa-honkanen, R. Honkanen, R. Antikainen, J. Hintikka, and H. Viinamaki, Self-reported life satisfaction and treatment factors in patients with schizophrenia, major depression and anxiety disorder, Acta Psychiatrica Scandinavica, vol.59, issue.5, pp.377-84, 1999.
DOI : 10.1111/j.1600-0447.1999.tb07244.x

J. Lebow, Pragmatic decisions in the evaluation of consumer satisfaction with mental health treatment, Evaluation and Program Planning, vol.5, issue.4, pp.349-56, 1982.
DOI : 10.1016/0149-7189(82)90007-6

M. Liang, A. Fossel, and M. Larson, Comparisons of Five Health Status Instruments for Orthopedic Evaluation, Medical Care, vol.28, issue.7, pp.632-674, 1990.
DOI : 10.1097/00005650-199007000-00008

J. Macfarlane, W. Holmes, R. Macfarlane, and N. Britten, Influence of patients' expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study, BMJ, vol.315, issue.7117, pp.1211-1215, 1997.
DOI : 10.1136/bmj.315.7117.1211

R. Mccabe, M. Saidi, and S. Priebe, Patient-reported outcomes in schizophrenia, The British Journal of Psychiatry, vol.191, issue.50, pp.21-29, 2007.
DOI : 10.1192/bjp.191.50.s21

L. Moret, J. Nguyen, N. Pillet, B. Falissard, P. Lombrail et al., Improvement of psychometric properties of a scale measuring inpatient satisfaction with care: a better response rate and a reduction of the ceiling effect, BMC Health Services Research, vol.318, issue.7200, p.197, 2007.
DOI : 10.1136/bmj.318.7200.1738

D. Naber, A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables, Int Clin Psychopharmacol, vol.10, issue.3, pp.133-141, 1995.

D. Naber and A. Karow, Good tolerability equals good results: the patient???s perspective, European Neuropsychopharmacology, vol.11
DOI : 10.1016/S0924-977X(01)00110-9

D. Naber, S. Moritz, M. Lambert, F. Pajonk, R. Holzbach et al., Improvement of schizophrenic patients??? subjective well-being under atypical antipsychotic drugs, Schizophrenia Research, vol.50, issue.1-2, pp.79-88, 2001.
DOI : 10.1016/S0920-9964(00)00166-3

M. Perreault, W. Rogers, P. Leichner, and S. Sabourin, Patients' requests and satisfaction with services in an outpatient psychiatric setting, Psychiatr Serv, vol.47, pp.287-92, 1996.

W. Redekop, M. Koopmanschap, R. Stolk, G. Rutten, B. Wolffenbuttel et al., Health-Related Quality of Life and Treatment Satisfaction in Dutch Patients With Type 2 Diabetes, Diabetes Care, vol.25, issue.3, pp.458-63, 2002.
DOI : 10.2337/diacare.25.3.458

A. Rouquette and B. Falissard, Sample size requirements for the internal validation of psychiatric scales, International Journal of Methods in Psychiatric Research, vol.11, issue.(1), pp.235-284, 2011.
DOI : 10.1002/mpr.352
URL : https://hal.archives-ouvertes.fr/inserm-00638404

M. Ruggeri, R. Dall-'agnola, and G. Bisoffi, FACTOR ANALYSIS OF THE VERONA SERVICE SATISFACTION SCALE-82 AND DEVELOPMENT OF REDUCED VERSIONS, International Journal of Methods in Psychiatric Research, vol.6, issue.1, pp.23-38, 1996.
DOI : 10.1002/(SICI)1234-988X(199604)6:1<23::AID-MPR147>3.3.CO;2-D

M. Ruggeri, A. Lasalvia, R. Dall-'agnola, B. Van-wijngaarden, H. Knudsen et al., Development, internal consistency and reliability of the Verona Service Satisfaction Scale-European Version. EPSILON Study 7. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs, Br J Psychiatry, pp.41-49, 2000.

L. Salomon, I. Gasquet, M. Mesbah, and P. Ravaud, Construction of a scale measuring inpatients' opinion on quality of care, International Journal for Quality in Health Care, vol.11, issue.6, pp.507-523, 1999.
DOI : 10.1093/intqhc/11.6.507

M. Spearing, R. Post, G. Leverich, D. Brandt, and W. Nolen, Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP, Psychiatry Research, vol.73, issue.3
DOI : 10.1016/S0165-1781(97)00123-6

L. Voruganti and A. Awad, Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia, Schizophrenia Research, vol.56, issue.1-2, pp.37-46, 2002.
DOI : 10.1016/S0920-9964(01)00161-X

E. Witthaus, J. Stewart, and C. Bradley, Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with Type 1 diabetes, Diabetic Medicine, vol.22, issue.Suppl. 1, pp.619-644, 2001.
DOI : 10.1046/j.1464-5491.2001.00529.x

H. Wolters, H. Knegtering, R. Van-den-bosch, and D. Wiersma, Effects and side effects of antipsychotic treatment in schizophrenia: Pros and cons of available self-rating scales, Schizophrenia Research, vol.112, issue.1-3
DOI : 10.1016/j.schres.2009.03.026

W. Zwick and W. Velicer, Comparison of five rules for determining the number of components to retain., Psychological Bulletin, vol.99, issue.3, pp.432-474, 1986.
DOI : 10.1037/0033-2909.99.3.432